【Heng Rong Science】The Company Signs MOU with Yi-Da Medical Center for Accelerator-Based Boron Neutron Capture Therapy (AB-BNCT) Center Establishment
Key facts
- 【Heng Rong Science】The Company Signs MOU with Yi-Da Medical Center for Accelerator-Based Boron Neutron Capture Therapy (AB-BNCT) Center Establishment
- Heng Rong Science and Yi-Da Medical Center have signed an MOU to establish an AB-BNCT center, aiming to advance cancer treatment technology.
- Source: PR Times
- Date: June 15, 2026
Direct answer
Heng Rong Science and Yi-Da Medical Center have signed an MOU to establish an AB-BNCT center, aiming to advance cancer treatment technology.
- Citation
- 【Heng Rong Science】The Company Signs MOU with Yi-Da Medical Center for Accelerator-Based Boron Neutron Capture Therapy (AB-BNCT) Center Establishment (June 15, 2026), PR Times
- Source
- PR Times
- Date
- June 15, 2026
Heng Rong Science and Yi-Da Medical Center have signed an MOU to establish an AB-BNCT center, aiming to advance cancer treatment technology.
📋 Article Processing Timeline
- 📰 Published: June 15, 2026 at 09:00
- 🔍 Collected: June 16, 2026 at 17:00 (32h 0m after Published)
- 🤖 AI Analyzed: June 16, 2026 at 17:10 (10 min after Collected)
The Company has signed a Memorandum of Understanding (MOU) with Yi-Da Medical Center for the establishment of an Accelerator-Based Boron Neutron Capture Therapy (AB-BNCT) center. Both parties will further exchange and evaluate AB-BNCT-related clinical applications, specialty medical development, treatment center planning, and future cooperation models. Yi-Da Medical Center is a leading institution in cancer care and academic research in southern Taiwan, dedicated to cancer prevention and the development of advanced medical technologies. It possesses a dedicated cancer treatment area and a multidisciplinary medical team. The Company focuses on the development of AB-BNCT systems and related technologies, with capabilities in equipment integration, technology R&D, and clinical application promotion.
FAQ
What is the purpose of the collaboration between Heng Rong Science and Yi-Da Medical Center?
To advance the clinical application and market expansion of AB-BNCT technology.
What is Yi-Da Medical Center's contribution to AB-BNCT technology?
As a leading institution in cancer care and academic research in southern Taiwan, it has a dedicated cancer treatment area and a multidisciplinary medical team.
What are Heng Rong Science's strengths in AB-BNCT technology?
Capabilities in equipment integration, technology R&D, and clinical application promotion.
What impact does this collaboration have on Heng Rong Science?
It contributes to the deepening of international layout and the development of AB-BNCT business.
What is the market potential of AB-BNCT technology?
The expansion of potential markets is expected.